𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Second line hormone therapy with aminoglutethimide versus medroxyprogesterone acetate in metastatic breast cancer

✍ Scribed by Silvestro, P.; Caparrotti, G.; Bruni, G.S.; Ferrari, E.; Maida, P.G.; Apice, G.; d'Alessio, A.; Monti, A.; Pergola, M.

Book ID
122018544
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
152 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cyclic and sequential therapy with tamox
Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer
✍ Takuma Nemoto; Dr. Jashbhai K. Patel; Dutzu Rosner; Thomas L. Dao; H. Halvorson πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

A clinical trial of sequential tamoxifen and medroxyprogesterone acetate (MPA) was carried out in 36 women with metastatic breast cancer in order to evaluate the therapeutic efficacy of this regimen and to determine if tamoxifen would increase progesterone receptor (PR) levels and thereby increase r